MWK are delighted to advise that Provocholine has recently been granted a licence for the UK market
More news to follow
Provocholine is available in the UK on a named patient only basis.
Provocholine® (methacholine chloride) is indicated for the diagnosis of bronchial airway hyperresponsiveness in subjects who do not have clinically apparent asthma.
The Provocholine® Challenge provides for a sensitive and generally accurate diagnosis of bronchial hyperreactivity as well as the severity of asthma. The Provocholine® Challenge can also be used to confirm occupational asthma.